{
    "ticker": "PNST",
    "name": "Penumbra, Inc.",
    "description": "Penumbra, Inc. is an innovative medical device company that specializes in the development of products for the treatment of vascular and neurovascular conditions. Founded in 2004, the company is dedicated to advancing the treatment of challenging medical conditions through its pioneering technologies. Penumbra's product portfolio includes a range of devices designed to address issues such as thrombectomy (the removal of blood clots), embolization, and neurovascular intervention. The company's flagship products, such as the Penumbra System, have been recognized for their effectiveness in treating ischemic stroke, providing clinicians with advanced tools to improve patient outcomes. With a strong focus on research and development, Penumbra is committed to driving innovation in the medical field and enhancing the quality of care for patients. The company collaborates closely with healthcare professionals to ensure that its products meet the evolving needs of the medical community. Penumbra's mission is to transform patient care through innovative solutions that improve the lives of patients facing serious health challenges.",
    "industry": [
        "Medical Devices",
        "Healthcare"
    ],
    "headquarters": "Alameda, California, USA",
    "founded": "2004",
    "website": "https://www.penumbrainc.com",
    "ceo": "Adam Elsesser",
    "social_media": {
        "twitter": "https://twitter.com/penumbrainc",
        "linkedin": "https://www.linkedin.com/company/penumbra-inc/"
    },
    "investor_relations": "https://investors.penumbrainc.com",
    "key_executives": [
        {
            "name": "Adam Elsesser",
            "position": "CEO"
        },
        {
            "name": "Harold S. H. Fong",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Neurovascular Products",
            "products": [
                "Penumbra System",
                "Jet 7 Reperfusion Catheter"
            ]
        },
        {
            "category": "Vascular Products",
            "products": [
                "ACE Catheter",
                "INDIGO Aspiration System"
            ]
        }
    ],
    "seo": {
        "meta_title": "Penumbra, Inc. | Innovative Medical Devices for Vascular and Neurovascular Treatments",
        "meta_description": "Discover Penumbra, Inc., a leader in medical device innovation for vascular and neurovascular conditions. Explore our advanced products and commitment to improving patient care.",
        "keywords": [
            "Penumbra",
            "Medical Devices",
            "Neurovascular",
            "Vascular",
            "Stroke Treatment",
            "Thrombectomy"
        ]
    },
    "faq": [
        {
            "question": "What does Penumbra specialize in?",
            "answer": "Penumbra specializes in developing medical devices for vascular and neurovascular conditions."
        },
        {
            "question": "Who is the CEO of Penumbra?",
            "answer": "Adam Elsesser is the CEO of Penumbra, Inc."
        },
        {
            "question": "Where is Penumbra headquartered?",
            "answer": "Penumbra is headquartered in Alameda, California, USA."
        },
        {
            "question": "What are some of Penumbra's main products?",
            "answer": "Some of Penumbra's main products include the Penumbra System, Jet 7 Reperfusion Catheter, and ACE Catheter."
        },
        {
            "question": "When was Penumbra founded?",
            "answer": "Penumbra was founded in 2004."
        }
    ],
    "competitors": [
        "SYK",
        "BSX",
        "ABT",
        "MDT"
    ],
    "related_stocks": [
        "AAPL",
        "GOOGL",
        "AMZN",
        "MSFT"
    ]
}